Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention
Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention have?
Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention has 209 citations in the OpenAlex counts ScholarIQ stores.
When was Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention published?
Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention has 2009 year in the ScholarIQ index.
What is the open-access status of Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention?
Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention has closed oa status in the ScholarIQ index.
What is the DOI of Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention?
The DOI for Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention is on the source record.
What is the PMID of Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention?
The PMID for Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention is on the source record.
What is the OpenAlex record for Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention?
The OpenAlex for Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention is on the source record.